BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25122780)

  • 1. Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation.
    Ai Y; Zhu D; Wang C; Su C; Ma J; Ma J; Wang X
    J Virol; 2014 Oct; 88(20):12112-22. PubMed ID: 25122780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small ruminant lentiviral Vif proteins commonly utilize cyclophilin A, an evolutionarily and structurally conserved protein, to degrade ovine and caprine APOBEC3 proteins.
    Yoshikawa R; Izumi T; Nakano Y; Yamada E; Moriwaki M; Misawa N; Ren F; Kobayashi T; Koyanagi Y; Sato K
    Microbiol Immunol; 2016 Jun; 60(6):427-36. PubMed ID: 27193350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cullin-elonginB-elonginC E3 complex in bovine immunodeficiency virus and maedi-visna virus Vif-mediated degradation of host A3Z2-Z3 proteins.
    Zhang J; Wu J; Wang W; Wu H; Yu B; Wang J; Lv M; Wang X; Zhang H; Kong W; Yu X
    Retrovirology; 2014 Sep; 11():77. PubMed ID: 25213124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular requirements for bovine immunodeficiency virus Vif-mediated inactivation of bovine APOBEC3 proteins.
    Zhang W; Wang H; Li Z; Liu X; Liu G; Harris RS; Yu XF
    J Virol; 2014 Nov; 88(21):12528-40. PubMed ID: 25142583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction.
    Zhang W; Du J; Evans SL; Yu Y; Yu XF
    Nature; 2011 Dec; 481(7381):376-9. PubMed ID: 22190036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolutionarily conserved requirement for core binding factor beta in the assembly of the human immunodeficiency virus/simian immunodeficiency virus Vif-cullin 5-RING E3 ubiquitin ligase.
    Han X; Liang W; Hua D; Zhou X; Du J; Evans SL; Gao Q; Wang H; Viqueira R; Wei W; Zhang W; Yu XF
    J Virol; 2014 Mar; 88(6):3320-8. PubMed ID: 24390335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3.
    Yoshikawa R; Takeuchi JS; Yamada E; Nakano Y; Misawa N; Kimura Y; Ren F; Miyazawa T; Koyanagi Y; Sato K
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clues for two-step virion infectivity factor regulation by core binding factor beta.
    Ai Y; Ma J; Wang X
    J Gen Virol; 2017 May; 98(5):1113-1121. PubMed ID: 28516844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vif determines the requirement for CBF-β in APOBEC3 degradation.
    Yoshikawa R; Takeuchi JS; Yamada E; Nakano Y; Ren F; Tanaka H; Münk C; Harris RS; Miyazawa T; Koyanagi Y; Sato K
    J Gen Virol; 2015 Apr; 96(Pt 4):887-892. PubMed ID: 25516542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accessory genes confer a high replication rate to virulent feline immunodeficiency virus.
    Troyer RM; Thompson J; Elder JH; VandeWoude S
    J Virol; 2013 Jul; 87(14):7940-51. PubMed ID: 23658451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a Cullin5-ElonginB-ElonginC E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteins.
    Wang J; Zhang W; Lv M; Zuo T; Kong W; Yu X
    J Virol; 2011 Dec; 85(23):12482-91. PubMed ID: 21957297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Investigation on the Interplay between Feline APOBEC3Z3 Proteins and Feline Immunodeficiency Virus Vif Proteins.
    Kosugi Y; Uriu K; Suzuki N; Yamamoto K; Nagaoka S; Kimura I; Konno Y; Aso H; Willett BJ; Kobayashi T; Koyanagi Y; Ueda MT; Ito J; Sato K
    J Virol; 2021 Jun; 95(13):e0017821. PubMed ID: 33762419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New World feline APOBEC3 potently controls inter-genus lentiviral transmission.
    Konno Y; Nagaoka S; Kimura I; Yamamoto K; Kagawa Y; Kumata R; Aso H; Ueda MT; Nakagawa S; Kobayashi T; Koyanagi Y; Sato K
    Retrovirology; 2018 Apr; 15(1):31. PubMed ID: 29636069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Naturally Occurring Domestic Cat APOBEC3 Variant Confers Resistance to Feline Immunodeficiency Virus Infection.
    Yoshikawa R; Izumi T; Yamada E; Nakano Y; Misawa N; Ren F; Carpenter MA; Ikeda T; Münk C; Harris RS; Miyazawa T; Koyanagi Y; Sato K
    J Virol; 2016 Jan; 90(1):474-85. PubMed ID: 26491161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentiviral Vif degrades the APOBEC3Z3/APOBEC3H protein of its mammalian host and is capable of cross-species activity.
    Larue RS; Lengyel J; Jónsson SR; Andrésdóttir V; Harris RS
    J Virol; 2010 Aug; 84(16):8193-201. PubMed ID: 20519393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maedi-visna virus Vif protein uses motifs distinct from HIV-1 Vif to bind zinc and the cofactor required for A3 degradation.
    Knecht KM; Hu Y; Rubene D; Cook M; Ziegler SJ; Jónsson SR; Xiong Y
    J Biol Chem; 2021; 296():100045. PubMed ID: 33465707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection.
    Jäger S; Kim DY; Hultquist JF; Shindo K; LaRue RS; Kwon E; Li M; Anderson BD; Yen L; Stanley D; Mahon C; Kane J; Franks-Skiba K; Cimermancic P; Burlingame A; Sali A; Craik CS; Harris RS; Gross JD; Krogan NJ
    Nature; 2011 Dec; 481(7381):371-5. PubMed ID: 22190037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A conflict of interest: the evolutionary arms race between mammalian APOBEC3 and lentiviral Vif.
    Nakano Y; Aso H; Soper A; Yamada E; Moriwaki M; Juarez-Fernandez G; Koyanagi Y; Sato K
    Retrovirology; 2017 May; 14(1):31. PubMed ID: 28482907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of efficient degradation of APOBEC3 restriction factors by HIV-1 Vif.
    Baig TT; Feng Y; Chelico L
    J Virol; 2014 Dec; 88(24):14380-95. PubMed ID: 25275135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lineage-Specific Viral Hijacking of Non-canonical E3 Ubiquitin Ligase Cofactors in the Evolution of Vif Anti-APOBEC3 Activity.
    Kane JR; Stanley DJ; Hultquist JF; Johnson JR; Mietrach N; Binning JM; Jónsson SR; Barelier S; Newton BW; Johnson TL; Franks-Skiba KE; Li M; Brown WL; Gunnarsson HI; Adalbjornsdóttir A; Fraser JS; Harris RS; Andrésdóttir V; Gross JD; Krogan NJ
    Cell Rep; 2015 May; 11(8):1236-50. PubMed ID: 25981045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.